Avet Pharma Announces the Launch of Losartan Tabs

Eatontown, NJ, March 1 2018. Avet Pharmaceuticals Inc. (“Avet”) announced the immediate availability of Losartan Potassium Film Coated immediate-release tablets: 25mg, 50mg, and 100mg. This launch adds to Avet’s robust portfolio of generic oral solid products. Losartan is the AB rated generic equivalent to the anti-hypertensive drug Cozaar®. It is indicated for the treatment of hypertension. According to IMS data for the twelve-months ended Feb. 2018, the U.S. market for Losartan immediate-release tablets is approximately $101.1 million.

Download Press Release